USPTO serial 79258436
SENZAGEN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 3, 2020
- Examiner
- KIDWELL WALKER, JACLYN NOEMI
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with SENZAGEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bradley L. Cohn
Bradley L. Cohn Pattishall, McAuliffe, et al200 South Wacker DriveChicago, IL 60606UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations for analysis of toxicological properties of chemical compounds and mixtures for scientific testing and screening purposes, performed in laboratories, research and scientific use; assays for analysis of toxicological properties of chemical compounds and mixtures for scientific testing and screening purposes, performed in laboratories, research and scientific use; diagnostic biomarkers for analysis of toxicological properties of chemical compounds and mixtures for scientific testing and screening purposes, performed in laboratories, research and scientific use; diagnostic preparations, assays and biomarkers for use in in vitro testing, assessment of toxicological properties of chemical compounds and mixtures, genomic analysis, assessment of chemical skin sensitizers, respiratory sensitizers and potency classification of chemicals, chemical compounds and mixtures, chemical sensitizers, agrochemicals, industrial chemicals, natural extracts, cosmetics and cosmetic ingredients, pharmaceuticals and pharmaceutical candidates, medical devices and materials, consumer products, for scientific testing and screening purposes, performed in laboratories for scientific testing and screening purposes; diagnostic preparations, assays and biomarkers for screening of pharmaceutical candidates, safety and potency classification of chemicals, safety and potency testing of cosmetic ingredients and assessment of sensitizers for industry and regulatory purposes, for scientific testing and screening purposes, and not for medical or veterinary use | ACTIVE | — |
| 005 | Diagnostic preparations for medical use; assays for medical use; diagnostic biomarkers for medical use; diagnostic preparations, assays and biomarkers for use in in vitro testing, assessment of toxicological properties of chemical compounds and mixtures, genomic analysis, assessment of chemical skin sensitizers, respiratory sensitizers and potency classification, all for medical testing and screening purposes; diagnostic preparations, assays and biomarkers for screening of pharmaceutical candidates, safety and potency classification of chemicals, safety and potency testing of cosmetic ingredients and assessment of sensitizers for industry and regulatory purposes in the medical and pharmaceutical industries, all for medical and pharmaceutical medical-based testing and screening purposes | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design in the field of genomics, in vitro and animal free testing, testing of toxicological properties of chemical compounds and mixtures and chemical sensitizers, screening of products, materials and substances for sensitizers, allergens and potency classification; scientific industrial analysis and research services in the field of genomics, in vitro and animal free testing, testing of toxicological properties of chemical compounds and mixtures and chemical sensitizers, screening of products, materials and substances for sensitizers, allergens and potency classification; scientific research and development; conducting research in the field of genomics and animal-free product testing; laboratory services in the field of genomics and animal-free product testing; in vitro analysis and dermal and respiratory analysis of chemicals, chemical compounds and mixtures, chemical sensitizers, agrochemicals, industrial chemicals, natural extracts, cosmetics and cosmetic ingredients, pharmaceuticals and pharmaceutical candidates, medical devices and materials, consumer products for scientific, medical and pharmaceutical research purposes; assessment of toxicological properties of chemical compounds and mixtures, for medical, pharmaceutical and scientific research services and for medical research and scientific research purposes; in vitro skin and respiratory sensitization analysis of chemicals, chemical compounds and mixtures, chemical sensitizers, agrochemicals, industrial chemicals, natural extracts, cosmetics and cosmetic ingredients, pharmaceuticals and pharmaceutical candidates, medical devices and materials, consumer products, for medical, pharmaceutical and scientific research services and for medical research and scientific research purposes; in vitro safety assessments of chemicals, chemical compounds and mixtures, chemical sensitizers, agrochemicals, industrial chemicals, natural extracts, cosmetics and cosmetic ingredients, pharmaceuticals and pharmaceutical candidates, medical devices and materials, consumer products, for medical, pharmaceutical and scientific research services and for medical research and scientific research purposes; in vitro testing for assessment of chemical skin sensitizers, respiratory sensitizers and potency classification for scientific, medical and pharmaceutical research services and for medical research and scientific research purposes; allergy analysis and animal-free allergy analysis of consumer products, chemical products, cosmetic products, pharmaceutical products and medical products for medical and pharmaceutical purposes; custom development of sensitization assays for prediction and classification of chemical sensitizers; safety and potency classification of chemicals, for medical, pharmaceutical and scientific research services; safety and potency testing of cosmetic ingredients; assessment of sensitizers for industry product testing and regulatory purposes in the medical and pharmaceutical industries; safety assessments of chemicals and proteins in the medical and pharmaceutical industries; in vitro product testing assessment of allergens, in the medical and pharmaceutical industries; sensitization product testing for the pharmaceutical, cosmetic and chemical industry; information, advisory and consultancy services relating to genomics, in vitro and animal free testing, testing of toxicological properties of chemical compounds and mixtures and chemical sensitizers, screening of products, materials and substances for sensitizers, allergens and potency classification, product testing assessment of toxicological properties of chemical compounds and mixtures for medical and pharmaceutical research purposes; animal-free product testing of chemical compounds, genomic product testing, animal-free genomic product testing, dermal and respiratory in vitro product testing and analysis, in vitro skin and respiratory sensitization product testing and analysis, in vitro product safety assessments, product testing and assessment of sensitizers, in vitro product testing for assessment of chemical skin sensitizers, respiratory sensitizers and potency classification, all for medical and pharmaceutical product safety purposes; screening of pharmaceutical candidates, safety and potency classification of chemicals, safety and potency testing of cosmetic ingredients and assessment of sensitizers for industry and regulatory purposes in the medical and pharmaceutical industries and for medical research and scientific research purposes; safety assessment of chemicals and proteins, in vitro assessment of allergens, all for medical and pharmaceutical purposes and for medical research and scientific research purposes; sensitization product testing for the pharmaceutical and cosmetic industries; in vitro safety and toxicity testing of medical devices | ACTIVE | — |
| 044 | In vitro testing for medical and pharmaceutical diagnostic purposes; allergy testing and animal-free allergy testing, all for medical and pharmaceutical diagnostic purposes; information, advisory and consultancy services relating thereto | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SenzaGen AB
- Other trademarks owned by SenzaGen AB
- Other trademarks owned by SenzaGen AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SENZAGEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 3, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 2, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 29, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 7, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 13, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 13, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 3, 2021 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Feb 3, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 3, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 8, 2020 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Aug 19, 2020 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Aug 18, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 18, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 14, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 29, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 29, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 29, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 24, 2020 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jul 16, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 16, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 16, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 16, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 16, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 10, 2020 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jan 29, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 29, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 29, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 23, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 23, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 23, 2019 | ALIE | ASSIGNED TO LIE | — |
| Dec 9, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 5, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 8, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 8, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 21, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 20, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 14, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 10, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| May 10, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 9, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |